Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

331.00
Delayed Data
As of Aug 04
 -3.92 / -1.17%
Today’s Change
201.91
Today|||52-Week Range
340.34
+28.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.7B3.7B4.1B4.2B
 
 
 
 
 
Cost of Goods Sold1.3B1.9B1.8B1.6B
 
 
 
 
 
Depreciation And Amortization472.4M938.2M938.0M982.6M
 
 
 
 
 
 
Operating ExpensesGross Income916.9M876.5M1.3B1.6B
 
 
 
 
 
General Expenses676.9M1.2B1.5B675.6M
 
 
 
 
 
Research And Development184.9M331.1M364.6M187.3M
 
 
 
 
 
Total Operating Expenses2.4B4.0B4.3B3.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income240.0M-359.0M-214.0M951.4M
 
 
 
 
 
Extraordinary Credit21.0M29.9M----
 
 
 
Extraordinary Charge-75.2M-701.3M-237.6M-1.5B
 
 
 
 
 
Pre-Tax Equity Earnings700.0K------
 
 
Interest Expense On Debt92.6M132.1M127.8M171.9M
 
 
 
 
 
Other Expenses-2.7M10.2M-220.6M34.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income92.4M-1.2B-794.9M-690.0M
 
 
 
 
 
Income Taxes-43.6M-107.9M-62.0M-177.7M
 
 
 
 
 
Minority Interest-100.0K0.000.00-300.0K
 
 
 
Preferred Dividend0.000.000.00-23.2M
 
 
Net Income48.7M-1.0B-732.9M-512.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS174.2M264.3M265.1M289.5M
 
 
 
 
 
Shares To Calculate EPS Diluted175.0M264.3M265.1M289.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.28-$3.95-$2.76-$1.85
 
 
 
 
 
EPS Diluted$0.28-$3.95-$2.76-$1.85